Logo image of IFX.CA

IMAFLEX INC (IFX.CA) Stock Fundamental Analysis

Canada - TSX-V:IFX - CA4524352099 - Common Stock

1.15 CAD
-0.03 (-2.54%)
Last: 9/17/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, IFX scores 6 out of 10 in our fundamental rating. IFX was compared to 7 industry peers in the Containers & Packaging industry. While IFX has a great health rating, its profitability is only average at the moment. IFX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes IFX very considerable for value investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

IFX had positive earnings in the past year.
IFX had a positive operating cash flow in the past year.
IFX had positive earnings in each of the past 5 years.
In the past 5 years IFX always reported a positive cash flow from operatings.
IFX.CA Yearly Net Income VS EBIT VS OCF VS FCFIFX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

IFX has a Return On Assets (2.51%) which is in line with its industry peers.
IFX has a Return On Equity of 3.52%. This is comparable to the rest of the industry: IFX outperforms 42.86% of its industry peers.
IFX has a Return On Invested Capital of 5.57%. This is comparable to the rest of the industry: IFX outperforms 42.86% of its industry peers.
IFX had an Average Return On Invested Capital over the past 3 years of 7.65%. This is in line with the industry average of 7.83%.
Industry RankSector Rank
ROA 2.51%
ROE 3.52%
ROIC 5.57%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
IFX.CA Yearly ROA, ROE, ROICIFX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

IFX's Profit Margin of 2.06% is in line compared to the rest of the industry. IFX outperforms 42.86% of its industry peers.
In the last couple of years the Profit Margin of IFX has grown nicely.
With a Operating Margin value of 5.03%, IFX is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of IFX has grown nicely.
The Gross Margin of IFX (14.65%) is worse than 71.43% of its industry peers.
IFX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.03%
PM (TTM) 2.06%
GM 14.65%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
IFX.CA Yearly Profit, Operating, Gross MarginsIFX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IFX is destroying value.
The number of shares outstanding for IFX remains at a similar level compared to 1 year ago.
Compared to 5 years ago, IFX has more shares outstanding
Compared to 1 year ago, IFX has an improved debt to assets ratio.
IFX.CA Yearly Shares OutstandingIFX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IFX.CA Yearly Total Debt VS Total AssetsIFX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

IFX has an Altman-Z score of 3.94. This indicates that IFX is financially healthy and has little risk of bankruptcy at the moment.
IFX has a Altman-Z score of 3.94. This is amongst the best in the industry. IFX outperforms 85.71% of its industry peers.
IFX has a debt to FCF ratio of 0.68. This is a very positive value and a sign of high solvency as it would only need 0.68 years to pay back of all of its debts.
IFX has a Debt to FCF ratio of 0.68. This is amongst the best in the industry. IFX outperforms 85.71% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that IFX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.11, IFX is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.68
Altman-Z 3.94
ROIC/WACC0.72
WACC7.71%
IFX.CA Yearly LT Debt VS Equity VS FCFIFX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

IFX has a Current Ratio of 2.51. This indicates that IFX is financially healthy and has no problem in meeting its short term obligations.
IFX's Current ratio of 2.51 is fine compared to the rest of the industry. IFX outperforms 71.43% of its industry peers.
A Quick Ratio of 1.69 indicates that IFX should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.69, IFX is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 1.69
IFX.CA Yearly Current Assets VS Current LiabilitesIFX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

6

3. Growth

3.1 Past

The earnings per share for IFX have decreased strongly by -49.23% in the last year.
IFX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 36.43% yearly.
IFX shows a small growth in Revenue. In the last year, the Revenue has grown by 6.69%.
Measured over the past years, IFX shows a small growth in Revenue. The Revenue has been growing by 6.26% on average per year.
EPS 1Y (TTM)-49.23%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-105.77%
Revenue 1Y (TTM)6.69%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%-8.45%

3.2 Future

The Earnings Per Share is expected to grow by 130.87% on average over the next years. This is a very strong growth
Based on estimates for the next years, IFX will show a quite strong growth in Revenue. The Revenue will grow by 13.35% on average per year.
EPS Next Y366.67%
EPS Next 2Y130.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.85%
Revenue Next 2Y13.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IFX.CA Yearly Revenue VS EstimatesIFX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
IFX.CA Yearly EPS VS EstimatesIFX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.75, the valuation of IFX can be described as expensive.
IFX's Price/Earnings ratio is a bit more expensive when compared to the industry. IFX is more expensive than 71.43% of the companies in the same industry.
IFX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.20.
IFX is valuated cheaply with a Price/Forward Earnings ratio of 6.98.
IFX's Price/Forward Earnings ratio is rather cheap when compared to the industry. IFX is cheaper than 100.00% of the companies in the same industry.
IFX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.75
Fwd PE 6.98
IFX.CA Price Earnings VS Forward Price EarningsIFX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

85.71% of the companies in the same industry are more expensive than IFX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IFX indicates a rather cheap valuation: IFX is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.52
EV/EBITDA 5.34
IFX.CA Per share dataIFX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IFX's earnings are expected to grow with 130.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)0.79
EPS Next 2Y130.87%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for IFX!.
Industry RankSector Rank
Dividend Yield N/A

IMAFLEX INC

TSX-V:IFX (9/17/2025, 7:00:00 PM)

1.15

-0.03 (-2.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)08-28 2025-08-28/bmo
Earnings (Next)11-26 2025-11-26
Inst Owners10.17%
Inst Owner ChangeN/A
Ins Owners46.37%
Ins Owner ChangeN/A
Market Cap59.90M
Analysts84.44
Price Target2.04 (77.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.73%
Min EPS beat(2)-100%
Max EPS beat(2)-51.46%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.83%
Min Revenue beat(2)-16.54%
Max Revenue beat(2)-5.12%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)180%
EPS NY rev (3m)180%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE 28.75
Fwd PE 6.98
P/S 0.55
P/FCF 4.52
P/OCF 3.6
P/B 0.94
P/tB 0.97
EV/EBITDA 5.34
EPS(TTM)0.04
EY3.48%
EPS(NY)0.16
Fwd EY14.32%
FCF(TTM)0.25
FCFY22.12%
OCF(TTM)0.32
OCFY27.79%
SpS2.09
BVpS1.23
TBVpS1.18
PEG (NY)0.08
PEG (5Y)0.79
Profitability
Industry RankSector Rank
ROA 2.51%
ROE 3.52%
ROCE 7.46%
ROIC 5.57%
ROICexc 6.52%
ROICexgc 6.77%
OM 5.03%
PM (TTM) 2.06%
GM 14.65%
FCFM 12.16%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
ROICexc(3y)8.55%
ROICexc(5y)12.05%
ROICexgc(3y)8.89%
ROICexgc(5y)12.53%
ROCE(3y)10.53%
ROCE(5y)14.7%
ROICexcg growth 3Y-20.84%
ROICexcg growth 5Y5.88%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y5.71%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.68
Debt/EBITDA 0.61
Cap/Depr 59.72%
Cap/Sales 3.12%
Interest Coverage 8.96
Cash Conversion 149.13%
Profit Quality 589.96%
Current Ratio 2.51
Quick Ratio 1.69
Altman-Z 3.94
F-Score6
WACC7.71%
ROIC/WACC0.72
Cap/Depr(3y)236.8%
Cap/Depr(5y)164.27%
Cap/Sales(3y)10.14%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.23%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-105.77%
EPS Next Y366.67%
EPS Next 2Y130.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.69%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%-8.45%
Revenue Next Year22.85%
Revenue Next 2Y13.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.17%
EBIT growth 3Y-9.43%
EBIT growth 5Y14.73%
EBIT Next Year119.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1195.21%
FCF growth 3Y29.22%
FCF growth 5Y23.11%
OCF growth 1Y39.55%
OCF growth 3Y25.19%
OCF growth 5Y10.31%